Cutting Edge Study: Half of Pharma and Medical Device Companies have Centralized Medical Affairs Teams
Sep 04, 2013 (Close-Up Media via COMTEX) --
Separating medical and commercial teams to avoid compliance issues, is the most important factor considered by drug and device companies when setting up their medical affairs organizational structure, reports Cutting Edge Information.
The company said its new study, "Medical Affairs: Resource Allocation for the Global Marketplace," found that one of the first decisions that companies make when structuring their medical affairs teams is whether to establish a centralized group that supports various parts of the company or a decentralized group. Half of the companies surveyed responded that they had centralized medical affairs teams in place.
According to a release, As long as information flows back and forth through the medical affairs structure, then the team can uphold its responsibility to respond to medical inquiries and disseminate medical evidence. "Aside from erecting a structural firewall between medical and marketing teams, there is no true best practice for configuring the actual medical affairs team's structure," said Ryan McGuire, research team leader at Cutting Edge Information.
Companies' medical affairs team structures vary widely. Some pharmas implement fully centralized medical affairs organizations in which global teams are responsible for executing strategy. Others operate fully decentralized functions in which country-level teams develop their own plans to support local market needs. Other options include a hybrid between centralized and decentralized teams to maximize the benefits of both structures.
Cutting Edge noted that the study found that the most significant medical affairs communications take place between its internal subteams and cross-functional groups, such as marketing and clinical development teams. As the medical affairs function has expanded over time, its need to coordinate across the company at a strategic level has only increased.
"Medical Affairs: Resource Allocation for the Global Marketplace" features detailed data on optimal medical affairs structures and best practices for cross-functional communication with clinical and marketing teams. The research includes four years of budget data for the overall medical affairs function.
((Comments on this story may be sent to firstname.lastname@example.org))
[ InfoTech Spotlight's Homepage ]